Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

BACKGROUND: Inhaled treprostinil is a prostacyclin analog approved for the treatment of pulmonary arterial hypertension (PAH) that may provide a more convenient treatment option for patients receiving inhaled iloprost while maintaining the clinical benefit of inhaled prostacyclin therapy. AIMS: In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourge, Robert C, Tapson, Victor F, Safdar, Zeenat, Benza, Raymond L, Channick, Richard N, Rosenzweig, Erika B, Shapiro, Shelley, White, Richard James, McSwain, Christopher Shane, Gotzkowsky, Stephen Karl, Nelsen, Andrew C, Rubin, Lewis J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561685/
https://www.ncbi.nlm.nih.gov/pubmed/22970909
http://dx.doi.org/10.1111/1755-5922.12008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561685/
https://www.ncbi.nlm.nih.gov/pubmed/22970909
http://dx.doi.org/10.1111/1755-5922.12008

Ejemplares similares